Mouse models for assessing the cross-protective efficacy of oral non-typhoidal salmonella vaccine candidates harbouring in-frame deletions of the ATP-dependent protease lon and other genes

Journal of Medical Microbiology

Volumn 64, Issue 3, 2015, Pages 295-302

  Matsui, Hidenori ^a   Fukiya, Satoru ^a,d   Kodama Akaboshi, Chie ^a,e   Eguchi, Masahiro ^b   Yamamoto, Tomoko ^c  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e KAWASAKI CITY INSTITUTE FOR PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NON TYPHOIDAL SALMONELLA VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; LIVE VACCINE; PRIMER DNA; TYPHOID PARATYPHOID VACCINE;

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE LON GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CROSS PROTECTION; FEMALE; GENE; GENE DELETION; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLOSIS; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; GENETICS; IMMUNOLOGY; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; SALMONELLA ENTERICA SEROVAR ENTERITIDIS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA INFECTIONS, ANIMAL; VIRULENCE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ATP-DEPENDENT PROTEASES; BACTERIAL PROTEINS; CROSS PROTECTION; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SALMONELLA ENTERITIDIS; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SEQUENCE DELETION; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED; VIRULENCE;

EID: 84923698125     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000014     Document Type: Article

References (36)

1. Alaniz, R. C., Deatherage, B. L., Lara, J. C. & Cookson, B. T. (2007). Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo. J Immunol 179, 7692–7701.
2. Bumann, D. (2014). Identification of protective antigens for vaccination against systemic salmonellosis. Front Immunol 5, 381.
3. Cerutti, A., Cols, M., Gentile, M., Cassis, L., Barra, C. M., He, B., Puga, I. & Chen, K. (2011). Regulation of mucosal IgA responses: lessons from primary immunodeficiencies. Ann N Y Acad Sci 1238, 132–144.
4. Cherepanov, P. P. & Wackernagel, W. (1995). Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158, 9–14.
5. Clementz, T., Zhou, Z. & Raetz, C. R. (1997). Function of the Escherichia coli msbB gene, a multicopy suppressor of htrB knockouts, in the acylation of lipid A. Acylation by MsbB follows laurate incorporation by HtrB. J Biol Chem 272, 10353–10360.
6. Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 6640–6645.
7. Eguchi, M., Sekiya, Y., Kikuchi, Y., Takaya, A., Yamamoto, T. & Matsui, H. (2007a). Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells. FEMS Immunol Med Microbiol 50, 411–420.
8. Eguchi, M., Sekiya, Y., Suzuki, M., Yamamoto, T. & Matsui, H. (2007b). An oral Salmonella vaccine promotes the down-regulation of cell surface Toll-like receptor 4 (TLR4) and TLR2 expression in mice. FEMS Immunol Med Microbiol 50, 300–308.
9. Eom, J. S., Seok Kim, J., Im Jang, J., Kim, B. H., Young Yoo, S., Hyeon Choi, J., Bang, I. S., Lee, I. S. & Keun Park, Y. (2013). Enhancement of host immune responses by oral vaccination to Salmonella enterica serovar Typhimurium harboring both FliC and FljB flagella. PLoS One 8, e74850.
10. Fass, E. & Groisman, E. A. (2009). Control of Salmonella pathogenicity island-2 gene expression. Curr Opin Microbiol 12, 199–204.
11. Germanier, R. & Füer, E. (1975). Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 131, 553–558.
12. Gulig, P. A. & Curtiss, R., III (1987). Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 55, 2891–2901.
13. Hassan, J. O. & Curtiss, R., III (1990). Control of colonization by virulent Salmonella typhimurium by oral immunization of chickens with avirulent DcyaDcrp S. typhimurium. Res Microbiol 141, 839–850.
14. Humphrey, S., Macvicar, T., Stevenson, A., Roberts, M., Humphrey, T. J. & Jepson, M. A. (2011). SulA-induced filamentation in Salmonella enterica serovar Typhimurium: effects on SPI-1 expression and epithelial infection. J Appl Microbiol 111, 185–196.
15. Kodama, C. & Matsui, H. (2004). Salmonella flagellin is not a dominant protective antigen in oral immunization with attenuated live vaccine strains. Infect Immun 72, 2449–2451.
16. Kodama, C., Eguchi, M., Sekiya, Y., Yamamoto, T., Kikuchi, Y. & Matsui, H. (2005). Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate. Microbiol Immunol 49, 1035–1045.
17. Lutkenhaus, J. & Addinall, S. G. (1997). Bacterial cell division and the Z ring. Annu Rev Biochem 66, 93–116.
18. MacLennan, C. A. & Levine, M. M. (2013). Invasive nontyphoidal Salmonella disease in Africa: current status. Expert Rev Anti Infect Ther 11, 443–446.
19. Mastroeni, P. & Ménager, N. (2003). Development of acquired immunity to Salmonella. J Med Microbiol 52, 453–459.
20. Matsui, H., Suzuki, M., Isshiki, Y., Kodama, C., Eguchi, M., Kikuchi, Y., Motokawa, K., Takaya, A., Tomoyasu, T. & Yamamoto, T. (2003). Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium. Infect Immun 71, 30–39.
21. Matulova, M., Havlickova, H., Sisak, F. & Rychlik, I. (2013). Vaccination of chickens with SPI1-lon and SPI1-lon-fliC mutant of Salmonella enterica serovar Enteritidis. PLoS One 8, e66172.
22. McGhie, E. J., Brawn, L. C., Hume, P. J., Humphreys, D. & Koronakis, V. (2009). Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol 12, 117–124.
23. Mizel, S. B. & Bates, J. T. (2010). Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185, 5677–5682.
24. Nakamura, M., Nagamine, N., Norimatsu, M., Suzuki, S., Ohishi, K., Kijima, M., Tamura, Y. & Sato, S. (1993). The ability of Salmonella enteritidis isolated from chicks imported from England to cause transovarian infection. J Vet Med Sci 55, 135–136.
25. Rabsch, W., Tschäpe, H. & Bäumler, A. J. (2001). Non-typhoidal salmonellosis: emerging problems. Microbes Infect 3, 237–247.
26. Ramos-Morales, F. (2012). Impact of Salmonella enterica Type III secretion system effectors on the eukaryotic host cell. ISRN Cell Biol 2012, 1–36.
27. Schmieger, H. (1972). Phage P22-mutants with increased or decreased transduction abilities. Mol Gen Genet 119, 75–88.
28. Silva, C. A., Blondel, C. J., Quezada, C. P., Porwollik, S., Andrews-Polymenis, H. L., Toro, C. S., Zaldívar, M., Contreras, I., McClelland, M. & Santiviago, C. A. (2012). Infection of mice by Salmonella enterica serovar Enteritidis involves additional genes that are absent in the genome of serovar Typhimurium. Infect Immun 80, 839–849.
29. Simon, R., Tennant, S. M., Galen, J. E. & Levine, M. M. (2011a). Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge. Vaccine 29, 5094–5106.
30. Simon, R., Tennant, S. M., Wang, J. Y., Schmidlein, P. J., Lees, A., Ernst, R. K., Pasetti, M. F., Galen, J. E. & Levine, M. M. (2011b). Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H: g,m flagellin as a candidate vaccine for protection against invasive infection with S. Enteritidis. Infect Immun 79, 4240–4249.
31. Simon, R., Wang, J. Y., Boyd, M. A., Tulapurkar, M. E., Ramachandran, G., Tennant, S. M., Pasetti, M., Galen, J. E. & Levine, M. M. (2013). Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharideflagellin glycoconjugates. PLoS One 8, e64680.
32. Stocker, B. A., Hoiseth, S. K. & Smith, B. P. (1983). Aromaticdependent “Salmonella sp.” as live vaccine in mice and calves. Dev Biol Stand 53, 47–54.
33. Takaya, A., Tomoyasu, T., Tokumitsu, A., Morioka, M. & Yamamoto, T. (2002). The ATP-dependent Lon protease of Salmonella enterica serovar Typhimurium regulates invasion and expression of genes carried on Salmonella pathogenicity island 1. J Bacteriol 184, 224–232.
34. Tsolis, R. M., Xavier, M. N., Santos, R. L. & Bäumler, A. J. (2011). How to become a top model: impact of animal experimentation on human Salmonella disease research. Infect Immun 79, 1806–1814.
35. Valdez, Y., Grassl, G. A., Guttman, J. A., Coburn, B., Gros, P., Vallance, B. A. & Finlay, B. B. (2009). Nramp1 drives an accelerated inflammatory response during Salmonella-induced colitis in mice. Cell Microbiol 11, 351–362.
36. Yamamoto, T., Sashinami, H., Takaya, A., Tomoyasu, T., Matsui, H., Kikuchi, Y., Hanawa, T., Kamiya, S. & Nakane, A. (2001). Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha. Infect Immun 69, 3164–3174.